FDA proposes replacing 'gender' with 'sex' in regulatory text
/ 1 min read
Table of Contents
The Food and Drug Administration (FDA) is reopening a period for public comment regarding a proposed change to its regulations.
Why it matters: This is a technical administrative change that updates how the agency writes its rules. While it involves changing specific terminology used in medical and regulatory documentation, the practical impact is primarily on how regulations are phrased rather than how drugs or devices are regulated.
Who it affects
- Medical researchers and pharmaceutical companies subject to FDA regulations
This information comes from a notice by the Food and Drug Administration; readers should consult the Federal Register before relying on these proposed changes.
Agency: Health and Human Services Department, Food and Drug Administration
Source: Federal Register — read the official document